Project leads
Collaborators

AMH, Inhibin A, FSH, and Ovarian Cancer Risk in the JANUS Serum Bank

Nicolas Wentzensen

2 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Follow

Louise Brinton

National Cancer Institute (NIH)

Rockville, United States

Elisabete Weiderpass

Cancer Registry of Norway

Oslo, Norway

Nicolas Wentzensen

National Cancer Institute (NIH)

Rockville, United States

Related projects

Nathaniel Rothman

Studies in the Janus Cohort

Nathaniel Rothman

DDT, PCBs, and Other Persistent Organohalide Chemicals in the JANUS Cohort

Hematology and hematologic malignancies Pathology

Thomas A Sellers

Follow-up of Ovarian Cancer Genetic Association and Interaction Studies (FOCI)

Selvendiran Karuppaiyah

Dissecting the Role of STAT3 and Targeting Ovarian Cancer

Hematology and hematologic malignancies Pathology

David Rueda

Single Molecule Imaging

Ovary Corpus uteri Colorectum Breast

Ram Prasad

Nanoprobe-amplified spectroscopic assay for accurate assessment of ovarian cancer burden in peripheral blood

Sohrab Shah

The clonal dynamics of ovarian cancers: phylogenetic models of chemosensitivity and resistance

David R Spriggs

Immunologic Approaches to Ovarian Cancer

Sandra Orsulic

(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women